Trademark Overview
On Thursday, September 12, 2024, a trademark application was filed for PARABILIS MEDICINES with the United States Patent and Trademark Office. The USPTO has given the PARABILIS MEDICINES trademark a serial number of 98746837. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 12, 2024. This trademark is owned by Fog Pharmaceuticals, Inc.. The PARABILIS MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
house mark for pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; House mark for pharmaceutical preparations; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
drug discovery services; Scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals
